Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134.2 USD | -2.13% | -0.97% | +6.39% |
Jun. 05 | European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading | MT |
Jun. 03 | Ascendis Pharma Reports 45% Clinical Response in TransCon IL-2 Phase 1/2 Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.39% | 7.87B | |
+18.20% | 125B | |
+13.51% | 108B | |
-7.23% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.23% | 16.37B | |
+1.28% | 13.58B | |
+27.78% | 11.66B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Ascendis Pharma Says US FDA Extends Review Period on Hypoparathyroidism Treatment; Shares Drop